0.29
-0.01 (-3.69%)
0.3003
+0.01 (+3.55%)
ChartMill assigns a Buy % Consensus number of 77% to KLDO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.91. This target is 4006.38% above the current price.
KLDO was analyzed by 12 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about KLDO.
In the previous month the buy percentage consensus was at a similar level.
KLDO was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-01-31 | Chardan Capital | Maintains | Buy |
| 2021-11-12 | Chardan Capital | Maintains | Buy |
| 2021-11-03 | JMP Securities | Maintains | Market Outperform |
| 2021-10-19 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2021-03-08 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-02-09 | Piper Sandler | Initiate | Overweight |
KALEIDO BIOSCIENCES INC / KLDO FAQ
What do analysts expect the price target to be for KALEIDO BIOSCIENCES INC (KLDO)?
12 analysts have analysed KLDO and the average price target is 11.91 null. This implies a price increase of 4006.38% is expected in the next year compared to the current price of 0.29.
Can you provide the consensus rating for KALEIDO BIOSCIENCES INC stock?
The consensus rating for KALEIDO BIOSCIENCES INC (KLDO) is 76.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed KALEIDO BIOSCIENCES INC (KLDO)?
The number of analysts covering KALEIDO BIOSCIENCES INC (KLDO) is 12.